Abstract
Drug rash with eosinophilia and systemic symptoms syndrome is a severe idiosyncratic drug reaction with a long latency period. It has been described using many terms; however, drug rash with eosinophilia and systemic symptoms syndrome appears to be the most appropriate. This syndrome causes a diverse array of clinical symptoms, anywhere from 2 to 8 weeks after initiating the offending drug. Standardized criteria for the diagnosis have been developed; however, their utility remains to be validated. Unfortunately, the management of drug rash with eosinophilia and systemic symptoms syndrome is not well supported by strong evidence-based data.
| Original language | English |
|---|---|
| Pages (from-to) | 31-37 |
| Number of pages | 7 |
| Journal | Journal of Clinical and Aesthetic Dermatology |
| Volume | 6 |
| Issue number | 6 |
| State | Published - Jun 1 2013 |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome. / Choudhary, Sonal; McLeod, Michael; Torchia, Daniele; Romanelli, Paolo.
In: Journal of Clinical and Aesthetic Dermatology, Vol. 6, No. 6, 01.06.2013, p. 31-37.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome
AU - Choudhary, Sonal
AU - McLeod, Michael
AU - Torchia, Daniele
AU - Romanelli, Paolo
PY - 2013/6/1
Y1 - 2013/6/1
N2 - Drug rash with eosinophilia and systemic symptoms syndrome is a severe idiosyncratic drug reaction with a long latency period. It has been described using many terms; however, drug rash with eosinophilia and systemic symptoms syndrome appears to be the most appropriate. This syndrome causes a diverse array of clinical symptoms, anywhere from 2 to 8 weeks after initiating the offending drug. Standardized criteria for the diagnosis have been developed; however, their utility remains to be validated. Unfortunately, the management of drug rash with eosinophilia and systemic symptoms syndrome is not well supported by strong evidence-based data.
AB - Drug rash with eosinophilia and systemic symptoms syndrome is a severe idiosyncratic drug reaction with a long latency period. It has been described using many terms; however, drug rash with eosinophilia and systemic symptoms syndrome appears to be the most appropriate. This syndrome causes a diverse array of clinical symptoms, anywhere from 2 to 8 weeks after initiating the offending drug. Standardized criteria for the diagnosis have been developed; however, their utility remains to be validated. Unfortunately, the management of drug rash with eosinophilia and systemic symptoms syndrome is not well supported by strong evidence-based data.
UR - http://www.scopus.com/inward/record.url?scp=84878911573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878911573&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84878911573
VL - 6
SP - 31
EP - 37
JO - Journal of Clinical and Aesthetic Dermatology
JF - Journal of Clinical and Aesthetic Dermatology
SN - 1941-2789
IS - 6
ER -